Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.93	72.9	76.68	108.91	77.83	63.56
Cash & Short-Term Investments	59.93	72.9	76.68	108.91	77.83	63.56
Cash Growth	-30.35%	-4.92%	-29.60%	39.93%	22.45%	586.84%
Prepaid Expenses	1.1	1.6	1.59	1.64	1.48	1.32
Restricted Cash	-	-	-	0.4	0.39	0.05
Other Current Assets	-	-	-	-	0.05	-
Total Current Assets	61.03	74.51	78.26	110.94	79.75	64.93
Property, Plant & Equipment	1.66	2.07	2.87	2.95	0.64	1.03
Other Long-Term Assets	0.33	0.32	0.31	0.3	-	0.44
Total Assets	63.02	76.9	81.45	114.19	80.39	66.4
Accounts Payable	7.71	7.57	7.95	10.13	5.54	4.34
Current Portion of Leases	0.6	0.58	0.54	0.5	0.31	0.43
Current Unearned Revenue	-	-	-	-	1	-
Total Current Liabilities	8.31	8.15	8.49	10.63	6.84	4.77
Long-Term Leases	0.69	0.99	1.57	2.08	0	0.31
Long-Term Unearned Revenue	35	35	35	35	-	-
Total Liabilities	44	44.14	45.07	47.71	6.84	5.08
Common Stock	0.03	0.03	0.03	0.03	0.02	0.02
Additional Paid-In Capital	417.62	408.55	373.93	355.22	329.27	292.28
Retained Earnings	-398.64	-375.83	-337.58	-288.77	-255.75	-230.97
Shareholders' Equity	19.01	32.76	36.38	66.48	73.55	61.32
Total Liabilities & Equity	63.02	76.9	81.45	114.19	80.39	66.4
Total Debt	1.29	1.57	2.11	2.58	0.31	0.74
Net Cash (Debt)	58.64	71.33	74.56	106.33	77.52	62.82
Net Cash Growth	-30.35%	-4.34%	-29.87%	37.16%	23.39%	702.73%
Net Cash Per Share	1.88	2.37	2.80	4.40	3.77	5.18
Filing Date Shares Outstanding	31.2	31.2	29.4	25.73	22.14	19.25
Total Common Shares Outstanding	31.2	31.2	27.63	25.67	22.14	17.53
Working Capital	52.72	66.36	69.77	100.31	72.91	60.16
Book Value Per Share	0.61	1.05	1.32	2.59	3.32	3.50
Tangible Book Value	19.01	32.76	36.38	66.48	73.55	61.32
Tangible Book Value Per Share	0.61	1.05	1.32	2.59	3.32	3.50
Machinery	-	1.26	1.24	1.09	0.68	0.6

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q